IRWD news

Latest 2 stories · newest Oct 16, 2026

IRWD

Ironwood Appoints Tammi Gaskins as New CEO

Ironwood Pharmaceuticals appointed Chief Commercial Officer Tammi Gaskins to succeed retiring CEO Tom McCourt as of January 1, 2027. The appointment signals a strategic leadership transition aimed at continuing the company's growth momentum in GI and rare disease therapies.

Leadership Oct 16, 2026 sentiment +0.30 SEC filing ↗

IRWD

IRONWOOD RAISES 2026 GUIDANCE AMID STRONG LINZESS SALES

Ironwood Pharmaceuticals raised total revenue and adjusted EBITDA guidance for 2026, citing strong LINZESS performance, while also repaying convertible notes and initiating a confirmatory Phase 3 trial for apraglutide.

Guidance Aug 6, 2026 sentiment +0.33 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same IRWD feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/IRWD/newsSTART FREE